UK Rare Disease Drug Review Reform Urged As Spinraza Finally Gets NICE OK

It has taken 17 months of negotiations but soon 600-1,200 people in the UK may be able to get Biogen's spinal muscular atrophy therapy now that an access agreement has been inked.